Hematology History
Pre-colonial West Africa (Ga, Ewe, and Krobo oral traditions); first Western clinical record 1910, Chicago, USA (Herrick and Irons case report)
Sickle cell disease occupies a unique position in medical history as one of the first conditions to be understood at the molecular level, bridging classical clinical observation and the emerging science of molecular biology in the mid-20th century. Long recognized within West African oral traditions and folk medicine long before it entered Western scientific literature, the condition's formal medical history spans from a 1910 case report in Chicago to Linus Pauling's landmark 1949 description of it as a 'molecular disease.' Its history is also deeply intertwined with broader histories of genetics, population science, and the geography of human migration.
Historical Narrative
Within West African communities, particularly among the Ghanaian Krobo and Ewe peoples and neighboring groups, healers and families had long recognized a pattern of inherited illness involving episodes of severe pain and early death, known in various local traditions by names such as 'chwechheechwe' among the Ga people of Ghana, meaning roughly 'body biting.' Anthropologists and medical historians have documented these indigenous naming traditions as evidence that the condition was observed, named, and understood as a hereditary family affliction centuries before any Western medical documentation. These pre-colonial understandings, though framed in cultural and spiritual rather than biochemical terms, reflected sustained empirical observation of a real and consistent pattern.
The condition entered the formal record of Western medicine in 1910 when Chicago physician James Bryan Herrick published a case report describing the unusual, elongated, crescent-shaped red blood cells observed in the blood of Walter Clement Noel, a 20-year-old dental student from Grenada. Herrick's intern, Ernest Irons, had first drawn and described the abnormal cell shapes while preparing the case notes, and the two men's collaboration resulted in what is now recognized as the first published Western clinical and microscopic description of the condition. Herrick used the term 'peculiar elongated and sickle-shaped' cells, which gave rise to the eventual name.
Through the 1920s and 1930s, American physicians Verne Mason and others refined the clinical description of the condition. Mason formally introduced the term 'sickle cell anemia' in 1922. During this period, it was widely but incorrectly assumed within American medical institutions that the condition was exclusively a disease of people of African descent and largely overlooked as a research priority, a bias that historical scholars have since analyzed in the context of racial attitudes within early 20th-century medicine.
The most significant conceptual leap in the history of sickle cell disease came in 1949, when chemist Linus Pauling, working at the California Institute of Technology with colleagues Harvey Itano, Ibert Wells, and S.J. Singer, demonstrated through electrophoresis that the hemoglobin in the blood of affected individuals had a different electrical charge and therefore a different molecular structure than normal hemoglobin. Pauling's paper, published in the journal Science, introduced the concept of a 'molecular disease' — the idea that a heritable alteration in a specific protein molecule could be the direct cause of a disease state. This framing was revolutionary and helped establish the field that would later be called molecular medicine.
In 1956, British biochemist Vernon Ingram identified the precise molecular difference: a single amino acid substitution in the beta chain of hemoglobin, with valine replacing glutamic acid at one position. This finding, building on Pauling's electrophoresis work, was among the first demonstrations that a single point mutation in a gene could alter a protein's structure and produce a hereditary disease — a foundational insight for genetics and molecular biology as disciplines. The history of sickle cell disease thus became inseparable from the history of how 20th-century science came to understand the relationship between genes, proteins, and inherited conditions.
Key Historical Figures
Historical narrative only — this page describes how Sickle Cell Disease was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.